ArticleFrontiers in immunology2022

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model.

Yun Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.